PROFESSIONAL EDITION

The largest community of pharma leaders

Editor´s Pick

EU drugs regulator say no shortages yet, steering group to monitor

FRANKFURT (Reuters) - The European Union’s healthcare regulator said that no drug shortages or supply disruptions have been reported in the region but that...

Bristol-Myers’ multiple myeloma combo therapy fails study

(Reuters) - Bristol Myers Squibb Co said on Monday its combination therapy for multiple myeloma failed the main goal of improving progression-free survival in...

Takeda Initiates Development of a Plasma-Derived Therapy for COVID-19

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today will share with members of the United States Congress that it is...

Japan’s Takeda Pharma says it is developing coronavirus drug

FILE PHOTO: A Takeda logo is seen in its research hub in Cambridge, Massachusetts, U.S., November 26, 2018. REUTERS/Julie Steenhuysen TOKYO (Reuters) - Takeda...

China approves use of Roche arthritis drug for coronavirus patients

BEIJING (Reuters) - China will use a Roche Holding AG arthritis drug to treat some coronavirus patients in severe conditions, health authorities said on...

Roche gets U.S. breakthrough tag for liver cancer diagnosis approach

FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann ZURICH (Reuters) -...

Recent Articles